Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Abstract Text:

A prospective randomized trial of anthralin in Lassar's paste compared with anthralin in 0.0125% clobetasol propionate in the treatment of chronic plaque psoriasis was undertaken. The psoriatic skin of patients treated with the corticosteroid-anthralin combination cleared significantly more quickly than those treated with anthralin alone, with a mean time to clearance of 14.9 days compared with 18.5 days, and with lower concentrations of anthralin. No significant difference was found in the rate of relapse of the two treatment groups, with relapse occurring in over 80% of patients within one year. Anthralin in 0.0125% clobetasol propionate was found to be an effective agent in the treatment of chronic plaque psoriasis, and one that was cosmetically acceptable to patients and nursing staff. An important disadvantage, however, was the development of a staphylococcal folliculitis in four of the 35 patients in which it was used. Because of this, anthralin in Lassar's paste remains our standard inpatient therapy, although the ease of use and cosmetic acceptability of anthralin in clobetasol propionate make it a useful remedy for outpatient use.

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Publishing Authors By Initials

For similar therapeutics: phototherapy: ultraviolet therapy research abstracts see: therapeutics: phototherapy: ultraviolet therapy research

PUBMED ID PMID:

MEDLINE DATE:

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Journal Published:

PUBLICATION TYPE: Randomized Controlled Trial

Journal: Archives of dermatology

VOLUME: 124

Page Numbers: 548-50

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Apr

YEAR: 1988

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Keywords Mesh Terms:

KEYWORDS: Ultraviolet Therapy

MESH TERMS: chemically induced

Chemical & Substance for Abstract: Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis. Information

Substance Name: Coal Tar

Registry Number: 8007-45-2

Grant and Affiliation Information for Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.

AFFILIATION: Department of Dermatology, King's College Hospital, London, England.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis Related Publications

• Acne in an irradiated area.
• Anthralin-corticosteroid combination therapy in the treatment of chronic plaque psoriasis.
• Sunscreens.
• Tachyphylaxis to topically applied steroids.